Release Date: 11/03/19 10:33 Summary: Verdant Scheme Implementation Agreement Price Sensitive: Yes Download Document 15.22MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%